High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

This study has been withdrawn prior to enrollment.

(There were no patient enrolled in this study at this site)

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

Hackensack University Medical Center

ClinicalTrials.gov Identifier:

NCT00447356

First received: March 12, 2007

Last updated: May 9, 2013

Last verified: May 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given